Investigator-led trial of Lilly’s merestinib in solid tumours terminated

Investigator-led trial of Lilly’s merestinib in solid tumours terminated

Submitted by admin on April 29, 2024 - 11:24am
Source: 
Clinical Trials Arena
News Tags: 
Eli Lilly
merestinib
clinical trials
solid tumors
Headline: 
Investigator-led trial of Lilly’s merestinib in solid tumours terminated
snippet: 

Eli Lilly’s merestinib has seen its Phase Transition Success Rate (PTSR) drop after an investigator-led Phase II trial of the candidate in solid tumors was terminated.

Do Not Allow Advertisers to Use My Personal information